Motilal Oswal has issued a BUY recommendation on PPL Pharma with a target price of Rs 260, indicating a potential upside of 14.89% from the current price of Rs 226.31.
Bringing you the latest updates on finance, economies, stocks, bonds, and more. Stay informed with timely insights.
